Literature DB >> 8457254

Red cell filterability in cigarette smokers and its relations to cardiac hypertrophy.

S M Shasha1, H Kamal, B Kristal, G Galetzky, N Roguin, T Shkolnik.   

Abstract

The relationship among daily cigarette consumption, washed and non-washed RBC filterability time (FT) as an indicator of erythrocyte deformability and echocardiographic left ventricular mass (LVM) were examined in 25 clinically healthy smokers and in 25 non-smoking controls matched for sex and age. FT of non-washed RBC was significantly higher in smokers than in non-smokers (25.2 +/- 3.6 vs. 16.8 +/- 2.2 min, P < 0.001). A highly significant linear correlation between number of cigarette consumption and FT was found. These differences were not observed when RBC were washed three times with isotonic saline. LVM was significantly greater in smokers (85.5 +/- 13.4 g/m2) than in controls (61.8 +/- 6.7 g/m2, P < 0.001). A linear correlation between daily cigarette consumption and LVM was observed. A positive relationship between LVM and FT of non-washed RBC was also found. These results demonstrated that LVM is significantly elevated in smokers and is linearly correlated with both cigarette consumption and RBC filtratibility. The increased deformability found in smokers may be a determinant to the cardiac hypertrophy. The association of both elevated LVM and rheological impairment may indicate unfavourable prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457254     DOI: 10.1016/0021-9150(93)90226-k

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

Review 1.  Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.

Authors:  E Kaplinsky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

2.  Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension.

Authors:  E Sage Colombo; Joshua Davis; Mehran Makvandi; Mario Aragon; Selita N Lucas; Michael L Paffett; Matthew J Campen
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.